• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非精原细胞瘤性生殖细胞癌患者的生存情况:通过Cox回归和递归划分对国际生殖细胞癌协作组(IGCC)分类的综述

Survival of patients with nonseminomatous germ cell cancer: a review of the IGCC classification by Cox regression and recursive partitioning.

作者信息

van Dijk M R, Steyerberg E W, Stenning S P, Dusseldorp E, Habbema J D F

机构信息

Department of Public Health, Erasmus MC - University Medical Center Rotterdam, PO Box 1738, 3000 DR Rotterdam, The Netherlands.

出版信息

Br J Cancer. 2004 Mar 22;90(6):1176-83. doi: 10.1038/sj.bjc.6601665.

DOI:10.1038/sj.bjc.6601665
PMID:15026798
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2409665/
Abstract

The International Germ Cell Consensus (IGCC) classification identifies good, intermediate and poor prognosis groups among patients with metastatic nonseminomatous germ cell tumours (NSGCT). It uses the risk factors primary site, presence of nonpulmonary visceral metastases and tumour markers alpha-fetoprotein (AFP), human chorionic gonadotrophin (HCG) and lactic dehydrogenase (LDH). The IGCC classification is easy to use and remember, but lacks flexibility. We aimed to examine the extent of any loss in discrimination within the IGCC classification in comparison with alternative modelling by formal weighing of the risk factors. We analysed survival of 3048 NSGCT patients with Cox regression and recursive partitioning for alternative classifications. Good, intermediate and poor prognosis groups were based on predicted 5-year survival. Classifications were further refined by subgrouping within the poor prognosis group. Performance was measured primarily by a bootstrap corrected c-statistic to indicate discriminative ability for future patients. The weights of the risk factors in the alternative classifications differed slightly from the implicit weights in the IGCC classification. Discriminative ability, however, did not increase clearly (IGCC classification, c=0.732; Cox classification, c=0.730; Recursive partitioning classification, c=0.709). Three subgroups could be identified within the poor prognosis groups, resulting in classifications with five prognostic groups and slightly better discriminative ability (c=0.740). In conclusion, the IGCC classification in three prognostic groups is largely supported by Cox regression and recursive partitioning. Cox regression was the most promising tool to define a more refined classification. British Journal of Cancer (2004) 90, 1176-1183. doi:10.1038/sj.bjc.6601665 www.bjcancer.com Published online 24 February 2004

摘要

国际生殖细胞共识(IGCC)分类法可识别转移性非精原细胞性生殖细胞肿瘤(NSGCT)患者的预后良好、中等和不良组。它使用的风险因素包括原发部位、非肺内脏转移的存在以及肿瘤标志物甲胎蛋白(AFP)、人绒毛膜促性腺激素(HCG)和乳酸脱氢酶(LDH)。IGCC分类法易于使用和记忆,但缺乏灵活性。我们旨在通过对风险因素进行正式加权的替代建模,来检验IGCC分类法在辨别能力上的损失程度。我们用Cox回归和递归分割法分析了3048例NSGCT患者的生存率,以进行替代分类。预后良好、中等和不良组是基于预测的5年生存率划分的。通过对预后不良组进行亚组划分,对分类进行了进一步细化。主要通过自展校正c统计量来衡量分类表现,以表明对未来患者的辨别能力。替代分类中风险因素的权重与IGCC分类法中的隐含权重略有不同。然而,辨别能力并没有明显提高(IGCC分类法,c = 0.732;Cox分类法,c = 0.730;递归分割分类法,c = 0.709)。在预后不良组中可识别出三个亚组,从而产生了具有五个预后组且辨别能力稍强的分类(c = 0.740)。总之,三个预后组的IGCC分类法在很大程度上得到了Cox回归和递归分割法的支持。Cox回归是定义更精细分类的最有前景的工具。《英国癌症杂志》(2004年)90卷,1176 - 1183页。doi:10.1038/sj.bjc.6601665 www.bjcancer.com 2004年2月24日在线发表

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01f9/2409665/c3a73e80ce58/90-6601665f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01f9/2409665/09a450b060b4/90-6601665f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01f9/2409665/c3a73e80ce58/90-6601665f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01f9/2409665/09a450b060b4/90-6601665f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01f9/2409665/c3a73e80ce58/90-6601665f2.jpg

相似文献

1
Survival of patients with nonseminomatous germ cell cancer: a review of the IGCC classification by Cox regression and recursive partitioning.非精原细胞瘤性生殖细胞癌患者的生存情况:通过Cox回归和递归划分对国际生殖细胞癌协作组(IGCC)分类的综述
Br J Cancer. 2004 Mar 22;90(6):1176-83. doi: 10.1038/sj.bjc.6601665.
2
Cluster analysis of p53 and Ki67 expression, apoptosis, alpha-fetoprotein, and human chorionic gonadotrophin indicates a favorable prognostic subgroup within the embryonal carcinoma germ cell tumor.对p53和Ki67表达、细胞凋亡、甲胎蛋白及人绒毛膜促性腺激素进行聚类分析,结果表明胚胎性癌生殖细胞肿瘤内存在一个预后良好的亚组。
J Clin Oncol. 2003 Jul 15;21(14):2679-88. doi: 10.1200/JCO.2003.03.136.
3
Improved long term survival of patients with metastatic nonseminomatous testicular germ cell carcinoma in relation to prognostic classification systems during the cisplatin era.在顺铂时代,转移性非精原细胞性睾丸生殖细胞癌患者的长期生存率与预后分类系统相关的改善情况。
Cancer. 2001 Apr 1;91(7):1304-15.
4
Survival of non-seminomatous germ cell cancer patients according to the IGCC classification: An update based on meta-analysis.根据国际生殖细胞癌协作组(IGCC)分类的非精原细胞性生殖细胞癌患者的生存率:基于荟萃分析的更新
Eur J Cancer. 2006 May;42(7):820-6. doi: 10.1016/j.ejca.2005.08.043. Epub 2006 Mar 30.
5
Early predicted time to normalization of tumor markers predicts outcome in poor-prognosis nonseminomatous germ cell tumors.肿瘤标志物早期预测的正常化时间可预测预后不良的非精原性生殖细胞肿瘤的结局。
J Clin Oncol. 2004 Oct 1;22(19):3868-76. doi: 10.1200/JCO.2004.04.008. Epub 2004 Aug 9.
6
Survival of metastatic germ cell cancer patients assessed by international germ cell consensus classification in Japan.在日本,通过国际生殖细胞癌共识分类评估的转移性生殖细胞癌患者的生存率。
Jpn J Clin Oncol. 2008 Apr;38(4):281-7. doi: 10.1093/jjco/hyn009. Epub 2008 Mar 4.
7
[Treatment decision in advanced testicular germ cell tumors].[晚期睾丸生殖细胞肿瘤的治疗决策]
Arch Esp Urol. 2000 Jul-Aug;53(6):522-33.
8
Prognostic factors in metastatic germ cell tumors.转移性生殖细胞肿瘤的预后因素
Semin Oncol. 1998 Apr;25(2):174-85.
9
Clinical outcome following post-chemotherapy retroperitoneal lymph node dissection in men with intermediate- and poor-risk nonseminomatous germ cell tumour.中高危和低危非精原细胞瘤男性患者化疗后腹膜后淋巴结清扫术的临床结局
BJU Int. 2007 May;99(5):993-7. doi: 10.1111/j.1464-410X.2007.06740.x.
10
International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group.国际生殖细胞共识分类:一种基于预后因素的转移性生殖细胞癌分期系统。国际生殖细胞癌协作组。
J Clin Oncol. 1997 Feb;15(2):594-603. doi: 10.1200/JCO.1997.15.2.594.

引用本文的文献

1
Very unusual case of a primary sinonasal germ cell tumour.原发性鼻窦生殖细胞肿瘤的极为罕见病例。
BMJ Case Rep. 2020 Feb 13;13(2):e232288. doi: 10.1136/bcr-2019-232288.
2
Development of a disease-specific graded prognostic assessment index for the management of sarcoma patients with brain metastases (Sarcoma-GPA).制定一种疾病特异性分级预后评估指标,用于管理患有脑转移的肉瘤患者(Sarcoma-GPA)。
BMC Cancer. 2020 Feb 12;20(1):117. doi: 10.1186/s12885-020-6548-6.
3
RNA binding motif protein 3: a potential biomarker in cancer and therapeutic target in neuroprotection.

本文引用的文献

1
Developing a prognostic model in the presence of missing data: an ovarian cancer case study.在存在缺失数据的情况下开发预后模型:一项卵巢癌病例研究。
J Clin Epidemiol. 2003 Jan;56(1):28-37. doi: 10.1016/s0895-4356(02)00539-5.
2
Treatment-induced anaemia and its potential clinical impact in patients receiving sequential high dose chemotherapy for metastatic testicular cancer.转移性睾丸癌患者接受序贯高剂量化疗时治疗引起的贫血及其潜在临床影响。
Br J Cancer. 2002 Nov 4;87(10):1066-71. doi: 10.1038/sj.bjc.6600629.
3
Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Münster (PROCAM) study.
RNA结合基序蛋白3:一种潜在的癌症生物标志物及神经保护的治疗靶点。
Oncotarget. 2017 Mar 28;8(13):22235-22250. doi: 10.18632/oncotarget.14755.
4
Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases.分级预后评估总结报告:一种准确且简便的诊断特异性工具,可用于评估脑转移患者的生存情况。
J Clin Oncol. 2012 Feb 1;30(4):419-25. doi: 10.1200/JCO.2011.38.0527. Epub 2011 Dec 27.
5
Effect of tumor subtype on survival and the graded prognostic assessment for patients with breast cancer and brain metastases.肿瘤亚型对乳腺癌脑转移患者生存的影响及分级预后评估。
Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):2111-7. doi: 10.1016/j.ijrobp.2011.02.027. Epub 2011 Apr 15.
6
A decision-analytic approach to define poor prognosis patients: a case study for non-seminomatous germ cell cancer patients.一种用于定义预后不良患者的决策分析方法:非精原细胞瘤性生殖细胞癌患者的案例研究
BMC Med Inform Decis Mak. 2008 Jan 3;8:1. doi: 10.1186/1472-6947-8-1.
7
[Secondary prevention after urological tumor diseases. Focusing on the kidneys, testes, and bladder].[泌尿系统肿瘤疾病后的二级预防。聚焦于肾脏、睾丸和膀胱]
Urologe A. 2007 Jun;46(6):636-41. doi: 10.1007/s00120-007-1353-2.
8
[Aftercare in testicular cancer is worthwhile. Recurrences are curable].睾丸癌的后续治疗是值得的。复发是可治愈的。
Urologe A. 2005 Sep;44(9):1024-30. doi: 10.1007/s00120-005-0881-x.
9
A prediction rule for selective screening of Chlamydia trachomatis infection.沙眼衣原体感染选择性筛查的预测规则。
Sex Transm Infect. 2005 Feb;81(1):24-30. doi: 10.1136/sti.2004.010181.
基于前瞻性心血管明斯特(PROCAM)研究10年随访结果计算急性冠脉事件风险的简易评分方案。
Circulation. 2002 Jan 22;105(3):310-5. doi: 10.1161/hc0302.102575.
4
Internal validation of predictive models: efficiency of some procedures for logistic regression analysis.预测模型的内部验证:逻辑回归分析中一些程序的效率
J Clin Epidemiol. 2001 Aug;54(8):774-81. doi: 10.1016/s0895-4356(01)00341-9.
5
Improved long term survival of patients with metastatic nonseminomatous testicular germ cell carcinoma in relation to prognostic classification systems during the cisplatin era.在顺铂时代,转移性非精原细胞性睾丸生殖细胞癌患者的长期生存率与预后分类系统相关的改善情况。
Cancer. 2001 Apr 1;91(7):1304-15.
6
Equivalence of three or four cycles of bleomycin, etoposide, and cisplatin chemotherapy and of a 3- or 5-day schedule in good-prognosis germ cell cancer: a randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group and the Medical Research Council.博来霉素、依托泊苷和顺铂三或四个周期化疗与3天或5天疗程在预后良好的生殖细胞癌中的等效性:欧洲癌症研究与治疗组织泌尿生殖系统癌症合作组和医学研究理事会的一项随机研究
J Clin Oncol. 2001 Mar 15;19(6):1629-40. doi: 10.1200/JCO.2001.19.6.1629.
7
Identification of prognostic subgroups among patients with metastatic 'IGCCCG poor-prognosis' germ-cell cancer: an explorative analysis using cart modeling.转移性“国际生殖细胞癌协作组预后不良”生殖细胞癌患者预后亚组的鉴定:使用分类回归树建模的探索性分析
Ann Oncol. 2000 Sep;11(9):1115-20. doi: 10.1023/a:1008333229936.
8
Prognostic modelling with logistic regression analysis: a comparison of selection and estimation methods in small data sets.基于逻辑回归分析的预后建模:小数据集中选择方法与估计方法的比较
Stat Med. 2000 Apr 30;19(8):1059-79. doi: 10.1002/(sici)1097-0258(20000430)19:8<1059::aid-sim412>3.0.co;2-0.
9
The National Cancer Data Base report on patterns of care for testicular carcinoma, 1985-1996.国家癌症数据库关于1985 - 1996年睾丸癌治疗模式的报告。
Cancer. 1999 Nov 15;86(10):2171-83.
10
First-line high-dose chemotherapy compared with standard-dose PEB/VIP chemotherapy in patients with advanced germ cell tumors: A multivariate and matched-pair analysis.一线大剂量化疗与标准剂量PEB/VIP化疗治疗晚期生殖细胞肿瘤患者的多因素及配对分析
J Clin Oncol. 1999 Nov;17(11):3450-6. doi: 10.1200/JCO.1999.17.11.3450.